The Endobronchial Ultrasound Biopsy Market is expected to reach US$ 1.27 billion by 2033 from US$ 820 million in 2024, with a CAGR of 5.03% from 2025 to 2033. One of the main factors propelling the ...
Occult lung adenocarcinoma was successfully diagnosed using endobronchial ultrasound-guided transbronchial needle aspiration ...
Dublin, Nov. 24, 2025 (GLOBE NEWSWIRE) -- The "United States Endobronchial Ultrasound Biopsy Market Report by Product, Application, End Use, States and Company Analysis, 2025-2033" report has been ...
October 25, 2011 (Honolulu, Hawaii) — Endobronchial ultrasound-guided biopsy transbronchial needle aspiration (EBUS) could cost about $2000 less per patient than mediastinoscopy in detecting ...
In this guidance, 'peripheral lung lesions' describes lung lesions that cannot be visualised using conventional bronchoscopy because they do not protrude into the bronchial tree. This guidance is ...
Introduction: Needle biopsy of enlarged lymph nodes is an accepted method for the diagnostic workup of sarcoidosis, but the optimal endosonography‑guided approach is yet to be determined. Objectives: ...
About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top ...
(MENAFN- GlobeNewsWire - Nasdaq) The United States endobronchial ultrasound (EBUS) biopsy market is projected to grow from USD 246.82 billion in 2024 to USD 356.2 billion by 2033, at a CAGR of 4.16%.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results